First Trust NYSE Arca Bio... (FBT)
NYSEArca: FBT
· Prix en temps réel · USD
271.87
+11.13 (4.27%)
À la clôture : Aug 19, 2026, 2:05 PM
271.87
+0.00%
Après-Bourse: 4:58 PM
First Trust NYSE Arca Biotechnology Index Fund (FBT) ETF Price, Holdings & Analysis
4.27% (1D)
| Bid | 271.32 |
| Capitalisation boursière | n/a |
| AUM | 2.66B |
| NAV | 259.64 |
| Bêta | 0.77 |
| EPS (ttm) | n / A |
| Rapport PE (ttm) | 29.16 |
| Parts en circulation | 20.85M |
| Date de création | Jun 19, 2006 |
| Ask | 271.5 |
| Volume | 50,765 |
| Moy. Volume (20D) | 66,058 |
| Ouverture | 265.83 |
| Clôture précédente | 260.74 |
| Fourchette du jour | 269.36 - 271.67 |
| Intervalle de 52 semaines | 171.00 - 271.67 |
| Positions | n / A |
| Ratio de frais | 0.55% |
À propos de FBT
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.
Classe d’actifs Equity
Symbole boursier FBT
Date de création Jun 19, 2006
Fournisseur First Trust
Site web Page d’accueil du fonds
Échange NYSEArca
10 principaux titres 36.19% des actifs
| Nom | Symbole | Poids |
|---|---|---|
| Corcept Therapeutics... | CORT | 4.23% |
| Neogenomics Inc | NEO | 3.70% |
| Regeneron Pharmaceut... | REGN | 3.65% |
| Halozyme Therapeutic... | HALO | 3.59% |
| Beone Medicines Ltd ... | ONC | 3.54% |
| Illumina Inc | ILMN | 3.54% |
| Bruker Corp | BRKR | 3.52% |
| Amgen Inc | AMGN | 3.51% |
| Incyte Corp | INCY | 3.46% |
| Veracyte Inc | VCYT | 3.45% |
Dividendes Rendement du dividende 0.43%
| Ex-dividende | Montant | Date de paiement |
|---|---|---|
| Dec 13, 2024 | $1.1730 | n / A |
| Dec 30, 2021 | $2.2140 | n / A |
| Sep 23, 2015 | $0.0200 | n / A |
| Jun 24, 2015 | $0.0650 | n / A |
| Mar 25, 2015 | $0.0480 | n / A |
3 semaines il y a · 24/7 Wall St.
FBT and IBB Are Not the Same Biotech Bet, and 5 Years of Returns Prove ItMost biotech investors treat FBT and IBB as two names for the same trade, but the structural differences buried in their index methodologies have produced shockingly different outcomes depending on wh...
Page 1 de 2